Celebrex Prescriptions Plunge After Risk Found-WSJ
626406
New prescriptions for Pfizer Inc.&#39;s arthritis drug Celebrex fell 56 percent last week after the company released data showing the drug may increase the risk of heart attacks and strokes, the Wall Street Journal said.
577633
The safety of Celebrex and other pain relievers was questioned Wednesday as scientists in the United States and regulatory agencies in Europe said they feared such drugs might raise the same risk of heart problems as those blamed on the arthritis medicine Vioxx.
478003
Stocks dropped in very heavy trading Friday as fresh concerns about pharmaceuticals, coming after Pfizer Inc. announced a troublesome health study of its Celebrex drug, overshadowed news of subdued growth in consumer prices and inflation.
182282
In New York, the blue-chip Dow Jones average fell on Thursday after drug maker Merck &amp; Co withdrew its widely used Vioxx painkiller after evidence showed the drug could increase risk of heart attack and stroke.
118026
A clinical trial of the blockbuster arthritis drug Celebrex was shut down Friday after researchers found an increase in the risk of serious heart disease and strokes in those taking the drug.
742151
The safety of Celebrex and other pain relievers was questioned Wednesday as scientists in the United States and regulatory agencies in Europe said they feared such drugs might raise the same risk of heart problems as those blamed on the arthritis medicine Vioxx.    One key researcher charged the U.S...
512331
Those taking Vioxx are twice as prone to cardiac problems than patients taking a placebo. Shares in Merck, the US pharmaceuticals giant, plunged by 27 per cent yesterday after the company withdrew Vioxx, its
718380
Risk is knocking Big Pharma stocks down. They won't be getting up anytime soon.
64708
Shares of Merck &amp; Co. plunged nearly 27 percent yesterday, pulling other stocks down with it, after the pharmaceutical giant yanked its Vioxx arthritis drug off the market because of heart safety concerns.
202222
Stocks were little changed on Friday,  recovering after a sharp early drop on news from Pfizer Inc.  PFE.N that patients in a study showed an increased risk of  heart attacks after taking its popular Celebrex drug.
633529
Doctors who led three studies showing prescription painkillers called COX-2 inhibitors raise the risk of heart attacks and stroke said on Tuesday the whole class of drugs was in danger of being pulled from the market.
643296
NEW YORK  - Drugs giant Pfizer Inc.&#39;s stock fell on a report that prescriptions for its blockbuster pain medication Celebrex slumped 56 percent last week.
444667
Pfizer&#39;s surprise announcement of possible health risks connected with its Celebrex drug pushed stocks lower in heavy trading Friday, renewing investors&#39; concerns over the pharmaceutical sector.
762997
For the people who have followed closely the unfolding concerns about popular arthritis medicines, the news that Celebrex may also be linked to a higher risk of stroke and heart attack holds little surprise.
502501
The Dow Jones industrial average fell  on Friday after Pfizer Inc. PFE.N shares opened nearly 19  percent down on trial data for its popular arthritis drug  Celebrex that showed increased risk of heart attack.
148090
TORONTO (CP) - Health authorities were left scrambling Friday when the company that makes one of the world's most popular pain relievers admitted Celebrex appears to increase the risk of heart attack in users.
570428
Concern over the recently publicized risks of drugs such as Vioxx and Celebrex has left doctors and patients with difficult choices.